Deutsche Bank raised the firm’s price target on HealthEquity to $88 from $85 and keeps a Buy rating on the shares following the fiscal Q3 report.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on HQY:
- HealthEquity price target raised to $93 from $89 at Wells Fargo
- HealthEquity sees FY25 revenue $1.14B-$1.16B, consensus $1.13B
- HealthEquity raises FY24 EPS view to $2.08-$2.16 from $1.97-$2.06
- HealthEquity reports Q3 EPS 60c, consensus 50c
- HealthEquity Reports Third Quarter Ended October 31, 2023 Financial Results
Questions or Comments about the article? Write to editor@tipranks.com